Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
We are seeking to out-license our innovative Soluleaves range More
SALINUM™ is a saliva substitute, indicated for the relief of symptoms of dry mouth, or xerostomia. More
Decapinol™ rinse contains a cationic surfactant Delmopinol Hydrochloride 2mg/ml; Decapinol rinse has a unique mode of action, which prevents the attachment as well as the adherence of plaque bacteria to the teeth, gingiva and to itself. More
Looking for partners to distribute highly innovative and effective oral care, skin care and Gynaecological pharmaceuticals More
This ORS effervescent tablet has been developed according to the latest guidelines of the WHO. We are looking for partners in Europe and in other areas to commercialize the ORS effervescent tablets More
A clinically-proven mucoadhesive oral rinse which is used in the management of mucositis More
Decapinol Gel, offers a novel and convenient way of treating periodontal disease. It contains 3 key ingredients - Delmopinol Hydrochloride (5mg/ml), Polyvinylpyrrolidone (PVP) and Hyaluronic Acid. More
SST is a pleasant-tasting pastille made up of organic acids and a calcium salt buffer for the management of Xerostomia (dry mouth). It is designed to support the production of saliva without causing or accelerating tooth decay. More
T-go (SPHO220) is indicated for the management of teething, including the relief of its most common symptoms, such as painful and swollen gums. More
Decapinol toothpaste containing Sodium Fluoride (NaF) 0.11% and Delmopinol 0.2% is a new addition to the Decapinol family and is indicated for the treatment of gingivitis and periodontitis. More
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Aphthous ulcers
- Dental disorder (other)
- Gingivitis
- Gum disease
- Herpes simplex virus type 1 (oral)
- Mouth disorder (other)
- Mucositis oral
- Mucositis, Radiation-induced
- Periodontal disease
- Tooth decay
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us